Djokovic buys 80% in Danish biotech Develi'nin COVID-19 treatment

Djokovic has 80 per cent stake in biotech firm developing Covid drug

Novak Djokovic has been revealed as a majority shareholder in a Danish biotech firm working looking to treat Covid without getting vaccinated.

Djokovic and Wife Own 80 Percent Stake in Biotech Company Developing Non-Vaccine COVID-19 Treatment: Report

Tennis star Novak Djokovic and his wife own an 80 percent share in a Danish biotech firm developing a treatment for ...

Tennis star Novak Djokovic has majority stake in biotech firm developing COVID-19 drug: CEO

Novak Djokovic, a tennis star from Serbia and currently the world number one is also a co-founder and majority shareholder of a biotech firm developing a coronavirus (COVID-19) treatment, CEO of the Danish company said on Wednesday (January 19).  Ivan Loncarevic, who is the boss of the company named QuantBioRes said that the tennis player's acquisition of the 80 per cent stake was made in June 2020. 

Novak Djokovic is the majority shareholder of a biotech company seeking a treatment for covid that does not require a vaccine - BBC News World

The number one in world tennis owns 80% of the company, which is looking for a cure for covid-19.

Novak Djokovic holds major stake in firm developing Covid drug: CEO

The unvaccinated men's world number one flew out of Melbourne on Sunday after he failed in a last-gasp court bid to stay and play in the opening Grand Slam of the year, where he was targeting a record 21st major title

Novak Djokovic Holds Major Stake In Firm Developing Covid Drug: CEO

Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is co-founder and majority shareholder of a biotech firm developing a Covid treatment, the Danish company's CEO said Wednesday.